Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 5Terminated 3Completed 3Withdrawn 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 1

Conditions

Ovarian Neoplasms 10Peritoneal Neoplasms 9Stomach Neoplasms 5Colorectal Neoplasms 5Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Appendiceal Neoplasms 3Recurrence 2Wilms Tumor 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Pseudomyxoma Peritonei 1Malignant Neoplasm of Colorectum 1Krukenberg Tumor 1Invasive Bladder Cancer 1Flushing 1Desmoplastic Small Round Cell Tumor 1Advanced Ovarian Cancer 1Acute Kidney Injury 1

Interventions

Carboplatin 87Paclitaxel 77Bevacizumab 38Topotecan 23liposomal doxorubicin 22Gemcitabine 22Taxes 21Cisplatin 17Drug Therapy 14Docetaxel 14Cyclophosphamide 14pembrolizumab 13Immunoglobulin G 12Disulfides 12veliparib 8rucaparib 8mirvetuximab soravtansine 8niraparib 7Albumin-Bound Paclitaxel 7sargramostim 6Filgrastim 6Erlotinib Hydrochloride 6Doxorubicin 6pazopanib 5Granulocyte-Macrophage Colony-Stimulating Factor 5Chemotherapy, Adjuvant 5CP protocol 5trebananib 4temsirolimus 4olaparib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Fallopian Tube Neoplasms × Hyperthermic Intraperitoneal Chemotherapy × Clear all
NCT04415944 2026-03-19

HIPEC

Wake Forest University Health Sciences

Phase 2 Completed
10 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT03604653 2022-08-03

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

Holy Name Medical Center, Inc.

Completed
10 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT01709487 2016-02-24

Feasibility Study of HIPEC for Patients With Stage III or Only Pleural Stage IV Ovarian Carcinoma in First Line Therapy

Jules Bordet Institute

Phase 1/2 Completed
19 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡